KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Is the neutrophil-lymphocyte ratio a good marker for the differential diagnosis of unstable angina pectoris and non-ST elevation myocardial infarction?
Aims: The aim of this study is to investigate the role of the neutrophil-lymphocyte ratio (NLR) in the differential diagnosis of non-ST elevation myocardial infarction (NSTEMI) and unstable angina pectoris (USAP).
Methods: Patients who had been admitted to the emergency ward with complaints of chest pain and who were diagnosed with USAP and NSTEMI in further examination were retrospectively included in this study. The NLR level was measured for each patient both at the times of application and of discharge. The NLR was calculated by dividing the neutrophil count by the lymphocyte count.
Results: WBC (8107.38±1405.5 vs 7452.46±1427.9, p: 0.020), neutrophil (5620 vs 4300, p: 0.001), and NLR (3.86 vs 2.14, p: 0.001) values were higher, whereas the lymphocyte value (1505 vs 2100, p: 0.001) was lower in the NSTEMI versus the USAP group. According to the multivariable logistic regression analysis that was done, NLR appeared to be an independent predictor of NSTEMI. The predictive value of NLR for NSTEMI diagnosis was >3.22 with 61.9% sensitivity and 86.96% specificity (74.3% positive predictive, 78.9% negative predictive) (AUC: 0.761; p< 0.001).
Conclusion: As cheapen inexpensive and easy-to-calculate index that can be applied in every medical establishment within the first 20 minutes of application, it is possible to state that NLR is a good marker in distinguishing NSTEMI from USAP patients.


1. Boden WE, Shah PK, Gupta V, Ohman EM. Contemporary approachto the diagnosis and management of non-ST-segment elevation acutecoronary syndromes. Prog Cardiovasc Dis 2008; 50: 311-51.
2. Rosamond W, Flegal K, Furie K, et al. American Heart AssociationStatistics Committee and Stroke Statistics Subcommittee. Heart diseaseand stroke statistics-2008 update: a report from the American HeartAssociation Statistics Committee and Stroke Statistics Subcommittee.Circulation 2008; 117: e25-146.
3. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 2009; 15: 36-41.
4. Turpie AG. Burden of disease: medical and economic impact of acutecoronary syndromes. Am J Manag Care 2006; 12: S430-4.
5. Ay&ccedil;a B, Akın F, Celik O, et al. Neutrophil to lymphocyte ratio is relatedto stent thrombosis and high mortality in patients with acute myocardialinfarction. Angiology 2015; 66: 545-52.
6. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil tolymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010; 106: 470-6.
7. Kaya A, Kurt M, Tanboğa IH. Neutrophil-to-lymphocyte ratio predictscontrast-induced nephropathy in patients undergoing primarypercutaneous coronary intervention. Angiology 2014; 65: 59.
8. A&ccedil;ar G, Fidan S, Uslu ZA, et al. Relationship of neutrophil-lymphocyteratio with the presence, severity, and extent of coronary atherosclerosisdetected by coronary computed tomography angiography. Angiology2015; 66: 174-9.
9. Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovasculardiseases: an update. Expert Rev Cardiovasc Ther 2016; 14: 573-7.
10. Akın F, Ay&ccedil;a B, &Ccedil;elik &Ouml;, Şahin C. Predictors of poor coronary collateraldevelopment in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets. Anatol J Cardiol 2015; 15: 218-23.
11. Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyteratio to coronary flow to in-hospital major adverse cardiac events inpatients with ST-elevated myocardial infarction undergoing primarycoronary intervention. Am J Cardiol 2012; 110: 621-7.
12. Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio isrelated to the severity of coronary artery disease and clinical outcome inpatients undergoing angiography. Atherosclerosis 2012; 225: 456-60.
13. Kirtane AJ, Bui A, Murphy SA, Barron HV, Gibson CM. Associationof peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol 2004; 93: 532-6.
14. Ates I, Ozkayar N, Topcuoglu C, Dede F. Relationship between oxidativestress parameters and asymptomatic organ damage in hypertensivepatients without diabetes mellitus. Scand Cardiovasc J 2015; 49: 249-56.
15. Thomson SP, Gibbons RJ, Smars PA, et al. Incremental value of theleukocyte differential and the rapid creatine kinase-MB isoenzyme forthe early diagnosis of myocardial infarction. Ann Intern Med 1995; 122:335-41.
16. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronaryartery bypass grafting. Am J Cardiol 2010; 105: 186-91.
17. Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic<br /> progression of coronary atherosclerosis. Angiology 2012; 63: 213-7.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentrationof low-density lipoprotein cholesterol in plasma, without use of thepreparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. Kurtul S, Sarli B, Baktir AO, et al. Neutrophil to lymphocyte ratio predictsSYNTAX score in patients with non-ST segment elevation myocardialinfarction. Int Heart J 2015; 56: 18-21.
20. Yilmaz M, Tenekecioglu E, Arslan B, et al. White blood cell subtypesand neutrophil-lymphocyte ratio in prediction of coronary thrombusformation in non-ST-segment elevated acute coronary syndrome. ClinAppl Thromb Hemost 2015; 21: 446-52.
21. Karabinos I, Koulouris S, Kranidis A, Pastromas S, Exadaktylos N,Kalofoutis A. Neutrophil count on admission predicts major in-hospitalevents in patients with a non-ST-segment elevation acute coronarysyndrome. Clin Cardiol 2009; 32: 561-8.
22. Sager HB, Nahrendorf M. Inflammation: a trigger for acute coronarysyndrome. Q J Nucl Med Mol Imaging 2016; 60: 185-93.
23. Ozt&uuml;rk S, Erdem A, Ozl&uuml; MF, et al. Assessment of the neutrophil tolymphocyte ratio in young patients with acute coronary syndromes. TurkKardiyol Dern Ars 2013; 41: 284-9.
24. Zazula AD, Pr&eacute;coma-Neto D, Gomes AM, et al. An assessment ofneutrophils / lymphocytes ratio in patients suspected of acute coronarysyndrome. Arq Bras Cardiol 2008; 90: 31-6.
25. Misumida N, Kobayashi A, Saeed M, Fox JT, Kanei Y. Neutrophil-to-lymphocyte ratio as an independent predictor of left main and/or three-vessel disease in patients with non-ST-segment elevation myocardialinfarction. Cardiovasc Revasc Med 2015; 16: 331-5.
26. Murasaki S, Murasaki K, Tanoue K, Kawana M, Hagiwara N, Kasanuki H. Circulating platelet and neutrophil activation correlates with the clinicalcourse of unstable angina. Heart Vessels 2007; 22: 376-82.
27. Gul M, Uyarel H, Ergelen M, et al. Predictive value of neutrophil tolymphocyte ratio in clinical outcomes of non-ST elevation myocardialinfarction and unstable angina pectoris: a 3-year follow-up. Clin ApplThromb Hemost 2014; 20: 378-84.
28. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclearleukocyte adhesion molecule during atherogenesis. Science 1991; 251:788-91.
29. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-26.
30. Keaney JF Jr, Vita JA. The value of inflammation for predicting unstableangina. N Engl J Med 2002; 347: 55-7.
31. Inagaki T, Akiyama T, Du CK, Zhan DY, Yoshimoto M, Shirai M.Monoamine oxidase-induced hydroxyl radical production andcardiomyocyte injury during myocardial ischemia-reperfusion in rats.Free Radic Res 2016; 50: 645-53.
32. Fan D, Yang Z, Yuan Y, et al. Sesamin prevents apoptosis and inflammationafter experimental myocardial infarction by JNK and NF-&kappa;B pathways.Food Funct 2017; 8: 2875-85.
Volume 1, Issue 1, 2021
Page : 13-18
_Footer